Compare JBTM & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JBTM | AMRX |
|---|---|---|
| Founded | 1994 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.4B |
| IPO Year | 2008 | 2018 |
| Metric | JBTM | AMRX |
|---|---|---|
| Price | $107.75 | $20.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $167.06 | $22.71 |
| AVG Volume (30 Days) | 416.9K | ★ 2.7M |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | ★ 0.37% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | ★ 1.40 | 0.37 |
| Revenue | ★ $3,798,200,000.00 | N/A |
| Revenue This Year | $5.89 | $4.53 |
| Revenue Next Year | $5.03 | $9.13 |
| P/E Ratio | $76.55 | ★ $54.59 |
| Revenue Growth | ★ 121.34 | N/A |
| 52 Week Low | $102.97 | $9.99 |
| 52 Week High | $170.19 | $21.18 |
| Indicator | JBTM | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.86 | 62.42 |
| Support Level | $103.26 | $16.59 |
| Resistance Level | $114.74 | $20.98 |
| Average True Range (ATR) | 2.87 | 0.62 |
| MACD | 0.52 | -0.02 |
| Stochastic Oscillator | 64.87 | 92.84 |
JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.